A Study to Determine the Safety and Efficacy of NT-501 With MHFM
Running, not enrolling · Phase 3
Conditions studied: Macular Telangiectasia Type 2
In brief
This study is to determine the long-term levels of CNTF, and the clinical safety and efficacy of the NT-501 implants with the Medica Hollow Fiber Membrane (MHFM) in participants with macular telangiectasia type 2.
Key facts
- Study ID
- NCT06397131
- Run by
- Neurotech Pharmaceuticals
- People needed
- 12
- Starts
- 2025-03-06
- Expected to finish
- 2026-07-24
- Last updated by the study team
- 2025-07-10
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Bay Area Retina Associates, A Medical Group — Walnut Creek, California, United States
- Foundation for Vision Research — Grand Rapids, Michigan, United States
- Retina Consultants of Texas — Bellaire, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.